IGHE and Alzheimer disease: Studies in mice showed that orally administered R. gnavus ATCC 29149 significantly reduced AD-associated parameters (i.e. transepidermal water loss, clinical score, total serum immunoglobulin (Ig) E level, OVA-specific IgE level, and skin inflammation) in a mouse model of AD (Ahn et al. 2022).